Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 21;45(44):4761-4764.
doi: 10.1093/eurheartj/ehae703.

The Netrod™ six-electrode radiofrequency renal denervation system for uncontrolled hypertension: a sham-controlled trial

Affiliations

The Netrod™ six-electrode radiofrequency renal denervation system for uncontrolled hypertension: a sham-controlled trial

Yueping Li et al. Eur Heart J. .
No abstract available

Keywords: Ambulatory blood pressure monitoring; Hypertension; Renal denervation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Blood pressure outcomes at 6 months post-procedure. (A) Changes in office and ambulatory SBP and DBP from baseline at 6 months post-procedure (RDN vs. sham control). Values are mean ± SD; RDN, renal denervation; BP, blood pressure; SBP, systolic BP; DBP, diastolic BP; 24H ASBP, 24 h ambulatory SBP; 24H ADBP, 24 h ambulatory DBP. Between-group differences were adjusted for the corresponding baseline BP measurements (using ANCOVA). Two patients (one in the RDN group and one in the sham group) were lost at 6-month follow-up. Last observation carried forward was used only for the primary endpoint (office SBP) analysis (RDN = 137, sham = 66); other endpoint analyses were based on RDN = 136, sham = 65. (B) Percentage of patients with SBP within target range (90 mmHg ≤ SBP < 140 mmHg). (C) Twenty-four hour ambulatory SBP at baseline and 6 months post-procedure (RDN vs. sham). Daytime is defined as 7 a.m. to 10 p.m., night-time 10 p.m. to 6 a.m.; error bars represent the standard error

References

    1. Symplicity HTN-2 Investigators . Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010;376:1903–9. 10.1016/S0140-6736(10)62039-9 - DOI - PubMed
    1. Bhatt DL, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014;370:1393–401. 10.1056/NEJMoa1402670 - DOI - PubMed
    1. Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet 2017;390:2160–70. 10.1016/S0140-6736(17)32281-X - DOI - PubMed
    1. Kandzari DE, Böhm M, Mahfoud F, Townsend RR, Weber MA, Pocock S, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet 2018;391:2346–55. 10.1016/S0140-6736(18)30951-6 - DOI - PubMed
    1. The SPYRAL HTN-OFF MED Pivotal Investigators . Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet 2020;395:1444–145. 10.1016/S0140-6736(20)30554-3 - DOI - PubMed